Separate R&D budget is needed for monitoring effects of new drugs

Entrustable professional activities for physiotherapists to demonstrate digital health competency: an international delphi study.

Physiotherapy theory and practice·2025

Endothelium-derived relaxing factor is an endogenous vasodilator in man.

British journal of pharmacology·2008

Drug discovery and development in the age of molecular medicine.

Clinical pharmacology and therapeutics·2007

Laser Doppler flowmetry detection of endothelial dysfunction in end-stage renal disease patients: correlation with cardiovascular risk.

Kidney international·2006

ADMA regulates angiogenesis: genetic and metabolic evidence.

Vascular medicine (London, England)·2005

Procedures for the outpatient management of patients with deep venous thrombosis.

Clinical and laboratory haematology·2005

Bat-borne zoonoses: transmission, impact, prevention, and management.

BMJ (Clinical research ed.)·2026

Evaluation of the accuracy, completeness, and compliance of current summary reporting of adverse events to the Food and Drug Administration using the manufacturer and user facility device experience (MAUDE) database: cross sectional study.

BMJ (Clinical research ed.)·2026

Drug-associated severe cutaneous adverse events in infants: Results of a disproportionality analysis from the USFDA adverse event reporting system.

Pediatrics and neonatology·2026

Current Pharmacovigilance Outsourcing Practices in Arab Countries.

Drug safety·2026

Disproportionality Analysis of Reporting Signals for Pericardial Disorders in the FDA Adverse Event Reporting System, 2000 to 2025.

Current drug safety·2026

Ocular safety signals of sphingosine-1-phosphate receptor modulators in postmarketing surveillance.

Frontiers in pharmacology·2026

Adaptation and factor analysis of a buprenorphine attitudes scale: Association with attitudes and dispensing practices among community pharmacists in Puerto Rico.

Journal of the American Pharmacists Association : JAPhA·2026

Disproportionality analysis of adverse event signals associated with seven Alzheimer's drugs: insights from the FAERS database.

Frontiers in pharmacology·2026

Related Experiment Videos

Separate R&D budget is needed for monitoring effects of new drugs

Related Concept Videos

Entrustable professional activities for physiotherapists to demonstrate digital health competency: an international delphi study.

Endothelium-derived relaxing factor is an endogenous vasodilator in man.

Drug discovery and development in the age of molecular medicine.

Laser Doppler flowmetry detection of endothelial dysfunction in end-stage renal disease patients: correlation with cardiovascular risk.

ADMA regulates angiogenesis: genetic and metabolic evidence.

Procedures for the outpatient management of patients with deep venous thrombosis.

Bat-borne zoonoses: transmission, impact, prevention, and management.

Evaluation of the accuracy, completeness, and compliance of current summary reporting of adverse events to the Food and Drug Administration using the manufacturer and user facility device experience (MAUDE) database: cross sectional study.

Drug-associated severe cutaneous adverse events in infants: Results of a disproportionality analysis from the USFDA adverse event reporting system.

Current Pharmacovigilance Outsourcing Practices in Arab Countries.

Disproportionality Analysis of Reporting Signals for Pericardial Disorders in the FDA Adverse Event Reporting System, 2000 to 2025.

Ocular safety signals of sphingosine-1-phosphate receptor modulators in postmarketing surveillance.

Adaptation and factor analysis of a buprenorphine attitudes scale: Association with attitudes and dispensing practices among community pharmacists in Puerto Rico.

Disproportionality analysis of adverse event signals associated with seven Alzheimer's drugs: insights from the FAERS database.

Related Experiment Videos

Separate R&D budget is needed for monitoring effects of new drugs

Related Concept Videos

Related Articles